Kuwait's Dasman Diabetes Institute signs agreement with the Forsyth Institute

October 12, 2010

CAMBRIDGE, Mass., October 12, -- In the face of a dramatic worldwide increase in adolescent obesity and Type 2 diabetes, The Forsyth Institute today announced a research alliance with the Dasman Diabetes Institute of Kuwait to initiate studies that could lay a scientific basis for prevention. This collaboration, called The Kuwait Healthy Life Study, will examine conditions in children that predispose them to obesity and Type 2 diabetes. In this five-year research alliance, Forsyth will work with the Dasman Diabetes Institute to conduct studies that are directed toward maintaining metabolic health in children and thereby preventing the consequences of obesity and diabetes.

The Forsyth scientists, world leaders in oral health research, will focus on using saliva as a source of non-invasive biomarkers of metabolic disease that are suitable as early warning risk indicators of developing diabetes.

Currently, diabetes is the sixth leading cause of death in the United States. The major recent change in this trend is that Type 2 diabetes (formerly called "adult-onset diabetes") has now become common in children. Complications of diabetes, which contribute to a shortening of lifespan, include cardiovascular disease, kidney disease, eye disease, nerve damage and foot infections. The percentage of people with diabetes in Kuwait is one of the highest worldwide.

The Forsyth team, led by J. Max Goodson, DDS, PhD, is developing diagnostic tools suitable for conducting a large-scale investigation of the disease conditions in children that lead to diabetes and testing the effectiveness of intervention based on life-style changes.

Forsyth has been working to safeguard the health of the children of Kuwait for 27 years (http://www.schooloralhealthkw.com/main_e.htm). Forsyth organizes and runs a dental care program that provides education, prevention and treatment to approximately 270,000 school children each year. This program is conducted in partnership with the government of Kuwait under the leadership of Dr. Sabiha Al-Mutawa, Superintendent of Oral Health, and Dr. Pramod Soparkar, Forsyth Senior Clinical Investigator. This initiative, the Kuwait-Forsyth School Oral Health program, offers an ideal source of participants for a longitudinal health study. The goals of the new Kuwait Healthy Life Study are: to develop methods for non-invasive detection of developing metabolic disease in children; to suggest potential mechanisms by which metabolic diseases develop; and to lay a scientific basis for prevention of Type 2 diabetes in children.

"The Dasman Diabetes Institute is at the forefront in creating global collaborations to improve the health of the people of Kuwait," said Dr. Kazem Behbehani, Director General of the Dasman Diabetes Institute. "This agreement is a natural extension of the long-standing relationship between Forsyth and Kuwait. We feel that that the key to control of obesity and type 2 diabetes may lay in recognizing and controlling the earliest symptoms of disease in children. This study should be of major benefit both to the people of Kuwait and the rest of the world that suffers from an epidemic increase in metabolic disease prevalence."

"We have worked with the public health and scientific communities in Kuwait for nearly three decades," said Dr. Philip Stashenko, President and CEO of The Forsyth Institute. "Our team is thrilled for the opportunity to expand our programs in Kuwait and work with leading scientists at the Dasman Diabetes Institute. Together, we have a great opportunity to create a paradigm shift in knowledge and improve health."

A unique characteristic of the Forsyth/Dasman alliance is that clinical research management will be largely by Kuwaiti scientists. To accomplish this, staff of the Kuwait University Faculty of Dentistry will participate in the studies being conducted at the Dasman Diabetes Institute. The alliance combines collaborations among three organizations, The Forsyth Institute, the Dasman Diabetes Institute and the Kuwait Dental School.
The vision of the Dasman Diabetes Institute (www.dasmaninstitute.org) is to be one of the leading comprehensive research and treatment facilities in its field, and to contribute to the improvement of the health of future generations in Kuwait and the entire Middle East. The Institute will achieve this vision by conducting research in the field of diabetes to find better treatment modalities and possible solutions to slow down the development of the disease in the region.

The Forsyth Institute is the world's leading independent organization dedicated to scientific research and education in oral health and related biomedical sciences. Established in 1910, Forsyth's mission is to lead the discovery, communication and application of breakthroughs in oral health and disease prevention that will significantly improve the health and well-being of the nation and the world. For more information about Forsyth visit its Web site at www.forsyth.org

Forsyth Institute

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.